Author:
Juan Angielyn San,Grayhack John J.
Publisher
Springer International Publishing
Reference21 articles.
1. Nowak KJ, Davies KE. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep. 2004;5(9):872–6. https://doi.org/10.1038/sj.embor.7400221.
2. Aartsma-Rus A, GInjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet. 2016;(53):145–51. https://doi.org/10.1136/jmedgenet-2015-103387&domain=pdf&date_stamp=2016-01-11.
3. Orrell RW. Diagnosing and managing muscular dystrophy. Practitioner. 2012;1754:21–4.
4. Omonova U. Clinical-diagnostic features of duchenne muscular dystrophy in children. Int J Biomed. 2013;4:266–8.
5. Bushby K, Birnkrant DJ, Clemens PR, Cripe L, Kaul A, Kinnett K, et al. Review diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet. 2009;9(1):1–17. https://doi.org/10.1016/S1474-4422(09)70271-6.